David S. Baldwin, MD, DM

Impairment of Sexual Desire in Treatment-Resistant Depression

November 22, 2022

Patients with treatment-resistant depression had a high prevalence of sexual desire impairment, which was associated with male sex and higher depressive symptom severity.

Walter dos Santos Gonçalves, Roseane Dorte Halkjaer Lassen, Aline Sardinha, et al

Original Research

Separation Anxiety and Suicide Risk

March 16, 2021

The link between suicidality and interpersonal difficulties extends the traditional approach of comprehending suicide as mainly related to depression. This study of adult outpatients investigated the link between separation...

Stefano Pini, Marianna Abelli, Barbara Costa, et al

Original Research

A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or Placebo

October 31, 2008

Barbara O. Rothbaum, Jonathan R. T. Davidson, Dan J. Stein, et al

Letter to the Editor

Reply to More on Placebo Response

December 14, 2007

Dan J. Stein, David S. Baldwin, Ornah T. Dolberg, et al

Original Research

Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram

November 15, 2006

Dan J. Stein, David S. Baldwin, Ornah T. Dolberg, et al

Original Research

What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

September 15, 2006

Borwin Bandelow, David S. Baldwin, Ornah T. Dolberg, et al

Article

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

June 15, 2006

David J. Nutt, David S. Baldwin, Anita H. Clayton, et al

Article

Symptoms of Fatigue and Sleepiness in Major Depressive Disorder

June 15, 2006

David S. Baldwin, George I. Papakostas

Original Research

Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey.

February 15, 2006

Valerie S. L. Williams, David S. Baldwin, Susan L. Hogue, et al

Article

Consensus Statement on Panic Disorder From the International Consensus Group on Depression and Anxiety

August 1, 1998

James C. Ballenger, Jonathan R. T. Davidson, Yves Lecrubier, et al

Article

The Side Effect Burden Associated With Drug Treatment of Panic Disorder

July 1, 1998

David S. Baldwin, Jon Birtwistle

Impairment of Sexual Desire in Treatment-Resistant Depression

Separation Anxiety and Suicide Risk

A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or Placebo

Reply to More on Placebo Response

Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram

What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Symptoms of Fatigue and Sleepiness in Major Depressive Disorder

Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey.

Consensus Statement on Panic Disorder From the International Consensus Group on Depression and Anxiety

The Side Effect Burden Associated With Drug Treatment of Panic Disorder

ELSEWHERE:

FOLLOW US:

David S. Baldwin, MD, DM

Impairment of Sexual Desire in Treatment-Resistant Depression

Separation Anxiety and Suicide Risk

A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or Placebo

Reply to More on Placebo Response

Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram

What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

Symptoms of Fatigue and Sleepiness in Major Depressive Disorder

Estimating the Prevalence and Impact of Antidepressant-Induced Sexual Dysfunction in 2 European Countries: A Cross-Sectional Patient Survey.

Consensus Statement on Panic Disorder From the International Consensus Group on Depression and Anxiety

The Side Effect Burden Associated With Drug Treatment of Panic Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles